CTRI/2020/09/027679
Not yet recruiting
未知
To assess the effect of canagliflozin in non diabetic proteinuric disease
COMMAND HOSPITAL AIR FORCE BANGALORE0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: N08- Glomerular disorders in diseases classified elsewhere
- Sponsor
- COMMAND HOSPITAL AIR FORCE BANGALORE
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patient in age group 18 to 75 years, registered in Nephrology OPD and was diagnosed as glomerulonephritis on the basis of renal biopsy and having proteinuria \> 1 gm/day
- •Should have e GFR \> 25 ml/min/1\.73 m2
- •The patient should be on a stable dose of an ACEi or ARB/immunosuppression for at least 4 weeks prior to randomization
Exclusion Criteria
- •Patient detected to be diabetic prior to enrolment or during the study
- •Patient lost to follow up during the study period
- •Patient whose baseline and follow up laboratory investigations, 24 hr urine protein, detailed renal biopsy report not available
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Effect of Canagliflozin in Non-diabetic overweight and obesity Patients with albuminuria: A Randomized, Double-blind, Placebo-controlled TrialEffect of Canagliflozin in Non-diabetic overweight and obesity Patients.Canagliflozin and Non-diabetic overweight and obesity PatientsTCTR20190203003Rachadaphiseksompot Endorsement Fund80
Completed
Not Applicable
Study of the beneficial effect of Canagliflozin on nocturnal home BP in Japanese T2DM patients(SHIFT-J STUDY)Type 2 diabetes mellitus patients with hypertensionJPRN-UMIN000023487Jichi Medical University School of Medicine100
Completed
Not Applicable
The effect of canagliflozin on the blood sugar levels of people without diabetes after weight loss surgeryHypoglycaemia after eating due to weight-loss surgerySurgeryISRCTN11342830niversity of Leicester36
Active, not recruiting
Phase 1
The effect of canagliflozin 300mg on glucose levels in people without diabetes after weight loss surgery.EUCTR2019-004041-32-GBniversity of Leicester24
Not yet recruiting
Not Applicable
Effect of canagliflozin as an alternative drug from DPP-4 inhibitor on heart failure with diabetis melltus : the pilot study "Can canagliflozin HAve Not only hypoGlycemic but cardiac supportive Effect?"chronic heart failure with type 2 diabetis mellitusJPRN-UMIN000031563Osaka Rosai Hospital40